HomeArticlesMeningioma (Dural Tail Sign, Hyperostosis, Sunburst Angiography & Brain Invasion)
NeuroradiologyHigh-Yield ReferenceHigh-Yield Clinical & Imaging Reference

Meningioma (Dural Tail Sign, Hyperostosis, Sunburst Angiography & Brain Invasion)

  • Seen in middle-aged to elderly adults (40–70 years, 2:1 female predilection) presenting with focal neurological deficits, new-onset seizures, chronic headaches, or detected incidentally on neuroimaging.
  • Caused by extra-axial neoplasm arising from the arachnoid cap cells of the arachnoid villi; predominantly benign (WHO Grade 1, 80–85%), but can be atypical (WHO Grade 2, 15–20%) or anaplastic/malignant (WHO Grade 3, 1–3%).

Imaging Findings

  • Brain MRI & CT (Extra-Axial Diagnostic Hallmark):
  • –
    Extra-Axial Mass Signs: Broad dural-based attachment, obtuse margins with the inner table of skull, buckling of underlying cerebral cortex, and CSF/vascular cleft separating tumor from brain parenchyma.
  • –
    Dural Tail Sign: Linear tapering enhancement of thickened dura extending away from the tumor margin (present in 60–72%; represents reactive hyperemia or neoplastic dural infiltration).
  • –
    Contrast Enhancement: Marked, avid, homogeneous enhancement on contrast-enhanced T1WI due to lack of a blood-brain barrier.
  • –
    CT Bone Window Pearls: Underlying hyperostosis of adjacent calvarium, intratumoral psammomatous calcifications (20–25%), and osteolysis (in high-grade/malignant subtypes).
  • –
    DWI / ADC: Typical WHO Grade 1 meningiomas are isointense or mildly hyperintense on DWI without marked restriction; marked diffusion restriction (low ADC) indicates hypercellularity and strongly suggests atypical (WHO Grade 2) or anaplastic (WHO Grade 3) meningioma.
  • –
    **SWI / T2* GRE: Demonstrates coarse blooming artifact from intratumoral psammomatous calcifications** (diamagnetic on phase-filtered SWI) and prominent intratumoral draining veins.
  • Conventional Angiography / Perfusion MRI:
  • –
    Classic 'sunburst' or 'spoke-wheel' radial vascular pattern arising predominantly from external carotid branches (middle meningeal artery) with persistent dense tumor blush lasting late into venous phase ('mother-in-law sign').
  • Brain Invasion Markers (WHO Grade 2 Criteria):
  • –
    Loss of CSF cleft, irregular finger-like tumor projections into adjacent brain parenchyma, and disproportionate vasogenic brain edema (T2/FLAIR hyperintensity).
  • Plain Radiograph (Skull X-Ray) Findings:
  • –
    Focal calvarial hyperostosis (sclerosis and thickening of the inner and outer skull tables), enlarged tortuous middle meningeal artery vascular grooves, and dense popcorn-like intratumoral psammomatous calcifications.

Differential Diagnosis

Meningioma (Dural Tail Sign, Hyperostosis, Sunburst Angiography & Brain Invasion) Differential Diagnosis Comparison Table — How Other Conditions Differ on CT, MRI, Ultrasound, and X-Ray
Differential DiagnosisKey Distinguishing Features
Dural Metastasis
Multiple dural-based enhancing lesions; associated with bone destruction rather than hyperostosis; known primary (breast, prostate, lung, melanoma); irregular nodular dural thickening without classic broad smooth base.
Hemangiopericytoma (Solitary Fibrous Tumor - SFT)
Lobulated, heterogeneous extra-axial mass with flow voids and osseous bone erosion without hyperostosis; marked T2 hypointensity; avid enhancement; high recurrence and systemic metastasis rate.
Schwannoma (CPA / Trigeminal)
Centered at neural exit foramina (internal auditory canal, Meckel cave); acute bony margins; heterogeneous enhancement with cystic changes; lacks adjacent hyperostosis or classic dural tail.
Glioblastoma (GBM) Abutting Dura
Intra-axial infiltrating mass with central necrosis, thick nodular peripheral ring-enhancement, restricted diffusion, and epicenter within the cerebral white matter rather than extra-axial broad dural base.

Important Points to Remember

  • Diagnostic Pitfall: Assuming every dural tail is a meningioma! A dural tail is NOT pathognomonic—it can be seen in dural metastases, schwannomas, glioblastomas abutting the dura, sarcoidosis, and lymphoma. Look for supporting features like adjacent calvarial hyperostosis, CSF cleft, and avid homogeneous enhancement. Furthermore, never underestimate a skull base meningioma: check for internal carotid artery narrowing without occlusion (meningiomas constrict arteries, whereas pituitary adenomas encase without narrowing).
  • Crucial Review Areas:
  • 1.
    Adjacent dural venous sinuses (superior sagittal sinus, transverse/sigmoid sinus) for invasion, partial filling defect, or complete occlusion on MR/CT venography.
  • 2.
    Underlying brain-tumor interface on T2/FLAIR for breach of the pial-arachnoid boundary (brain invasion = WHO Grade 2).
  • 3.
    Major traversing intracranial arteries (ICA, ACA, MCA) for arterial encasement and narrowing.
  • 4.
    Foramen magnum, optic canal, and cribriform plate for perineural skull base extension.
  • Case-Specific Radiologist Management:
  • 1.
    Immediate Verbal Alert: Direct telephone notification to neurosurgical registrar if acute mass effect with midline shift >5 mm, uncal/subfalcine herniation, or impending acute obstructive hydrocephalus is identified.
  • 2.
    Dedicated Pre-Surgical Venous Mapping (MRV/CTV): Mandatory contrast-enhanced MR/CT Venogram to evaluate dural venous sinus patency and collateral drainage pathways before planned surgical resection (Simpson Grade 1 resection).
  • 3.
    Preoperative Interventional Embolization Assessment: Coordinate with neuro-interventional radiology for pre-operative catheter angiography and superselective particle embolization of external carotid feeding vessels (middle meningeal artery) for large hypervascular skull base meningiomas to reduce intraoperative blood loss.
  • 4.
    Corticosteroid Protocol: Recommend immediate initiation of intravenous Dexamethasone (with PPI gastric protection) if marked vasogenic edema and symptomatic mass effect are present.
  • 5.
    Neuro-Oncology & Skull Base MDT: Present to the dedicated Neuro-Oncology Multidisciplinary Team to stratify between observation (small incidental calcified tumors), stereotactic radiosurgery (Gamma Knife / CyberKnife for unresectable skull base lesions), and craniotomy with microsurgical resection.

Related Neuroradiology Reference Articles

Pleomorphic Adenoma (Benign Mixed Tumour)

Seen in middle-aged adults (peak age 30–60 years, 2:1 female predominance; accounts for 70–80% of all parotid gland tumours and is the most common salivary gland neoplasm overall), presenting with a painless, slow-growing, firm, mobile mass at the angle of the mandible or pre-auricular cheek. Caused by a benign biphasi

Read article →
Warthin Tumour (Papillary Cystadenoma Lymphomatosum)

Seen in older adults (peak age 50–70 years, strong male predominance, with >90% occurring in cigarette smokers; second most common benign parotid neoplasm), presenting with a painless, slow-growing, soft or fluctuant mass classically in the inferior pole (tail) of the parotid gland. Caused by heterotopic salivary ducta

Read article →
Pituitary Macroadenoma (Sellar & Suprasellar Mass)

Seen in adults (peak age 30–60 years; accounts for 10–15% of all intracranial neoplasms and is the most common sellar/suprasellar mass in adults), presenting with bitemporal hemianopia (from superior compression of the optic chiasm), hypopituitarism, hyperprolactinaemia ('stalk effect' or prolactinoma), or acute thunde

Read article →
Craniopharyngioma (Adamantinomatous & Papillary)

Seen in a classic bimodal age distribution—the primary peak in children aged 5–15 years (most common pediatricnonglial suprasellar neoplasm) and a second peak in adults aged 50–70 years—presenting with visual field defects (bitemporal hemianopia), growth failure/short stature, diabetes insipidus, and obstructive hydroc

Read article →